159 related articles for article (PubMed ID: 15497760)
1. Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes.
Boyadzhiev L; Kancheva D; Gourdon C; Metcheva D
Pharmazie; 2004 Sep; 59(9):727-8. PubMed ID: 15497760
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant effect and study of bioactive components of Valeriana sisymbriifolia and Nardostachys jatamansii in comparison to Valeriana officinalis.
Dugaheh MA; Meisami F; Torabian Z; Sharififar F
Pak J Pharm Sci; 2013 Jan; 26(1):53-8. PubMed ID: 23261727
[TBL] [Abstract][Full Text] [Related]
3. Stability control of valerian ground material and extracts: a new HPLC-method for the routine quantification of valerenic acids and lignans.
Goppel M; Franz G
Pharmazie; 2004 Jun; 59(6):446-52. PubMed ID: 15248459
[TBL] [Abstract][Full Text] [Related]
4. [Studies on chemical constituents of Valeriana officinalis].
Jiang X; Zhang JC; Liu YW; Fang Y
Zhong Yao Cai; 2007 Nov; 30(11):1391-3. PubMed ID: 18323205
[TBL] [Abstract][Full Text] [Related]
5. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier.
Neuhaus W; Trauner G; Gruber D; Oelzant S; Klepal W; Kopp B; Noe CR
Planta Med; 2008 Sep; 74(11):1338-44. PubMed ID: 18704879
[TBL] [Abstract][Full Text] [Related]
6. Three phases hollow fiber LPME combined with HPLC-UV for extraction, preconcentration and determination of valerenic acid in Valeriana officinalis.
Mirzaei M; Dinpanah H
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1870-4. PubMed ID: 21641881
[TBL] [Abstract][Full Text] [Related]
7. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid.
Trauner G; Khom S; Baburin I; Benedek B; Hering S; Kopp B
Planta Med; 2008 Jan; 74(1):19-24. PubMed ID: 18095218
[TBL] [Abstract][Full Text] [Related]
8. Valerenic acid derivatives and valepotriates among individuals, varieties and species of Valeriana.
Gao XQ; Björk L
Fitoterapia; 2000 Feb; 71(1):19-24. PubMed ID: 11449465
[TBL] [Abstract][Full Text] [Related]
9. Chemical fingerprinting of valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection.
Navarrete A; Avula B; Choi YW; Khan IA
J AOAC Int; 2006; 89(1):8-15. PubMed ID: 16512222
[TBL] [Abstract][Full Text] [Related]
10. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
[TBL] [Abstract][Full Text] [Related]
11. Root colonization by symbiotic arbuscular mycorrhizal fungi increases sesquiterpenic acid concentrations in Valeriana officinalis L.
Nell M; Wawrosch C; Steinkellner S; Vierheilig H; Kopp B; Lössl A; Franz C; Novak J; Zitterl-Eglseer K
Planta Med; 2010 Mar; 76(4):393-8. PubMed ID: 19809971
[TBL] [Abstract][Full Text] [Related]
12. Impact of Altitudes and Habitats on Valerenic Acid, Total Phenolics, Flavonoids, Tannins, and Antioxidant Activity of Valeriana jatamansi.
Jugran AK; Bahukhandi A; Dhyani P; Bhatt ID; Rawal RS; Nandi SK
Appl Biochem Biotechnol; 2016 Jul; 179(6):911-26. PubMed ID: 26971960
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.
Lefebvre T; Foster BC; Drouin CE; Krantis A; Livesey JF; Jordan SA
J Pharm Pharm Sci; 2004 Aug; 7(2):265-73. PubMed ID: 15367385
[TBL] [Abstract][Full Text] [Related]
14. Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish).
Torres-Hernández BA; Del Valle-Mojica LM; Ortíz JG
BMC Complement Altern Med; 2015 Jul; 15():228. PubMed ID: 26168917
[TBL] [Abstract][Full Text] [Related]
15. (-)-3 beta,4 beta-epoxyvalerenic acid from Valeriana officinalis.
Dharmaratne HR; Nanayakkara NP; Khan IA
Planta Med; 2002 Jul; 68(7):661-2. PubMed ID: 12143008
[TBL] [Abstract][Full Text] [Related]
16. Regulation of sesquiterpenoid metabolism in recombinant and elicited Valeriana officinalis hairy roots.
Ricigliano V; Kumar S; Kinison S; Brooks C; Nybo SE; Chappell J; Howarth DG
Phytochemistry; 2016 May; 125():43-53. PubMed ID: 26920719
[TBL] [Abstract][Full Text] [Related]
17. Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity.
Felgentreff F; Becker A; Meier B; Brattström A
Phytomedicine; 2012 Oct; 19(13):1216-22. PubMed ID: 22944521
[TBL] [Abstract][Full Text] [Related]
18. Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation.
Nam SM; Choi JH; Yoo DY; Kim W; Jung HY; Kim JW; Kang SY; Park J; Kim DW; Kim WJ; Yoon YS; Hwang IK
Exp Gerontol; 2013 Nov; 48(11):1369-77. PubMed ID: 24055511
[TBL] [Abstract][Full Text] [Related]
19. Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uterine muscle.
Occhiuto F; Pino A; Palumbo DR; Samperi S; De Pasquale R; Sturlese E; Circosta C
J Pharm Pharmacol; 2009 Feb; 61(2):251-6. PubMed ID: 19178774
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women.
Anderson GD; Elmer GW; Taibi DM; Vitiello MV; Kantor E; Kalhorn TF; Howald WN; Barsness S; Landis CA
Phytother Res; 2010 Oct; 24(10):1442-6. PubMed ID: 20878691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]